Non-Small Cell Lunch Cancer
1 clinical trials · Condition
◉ Watch Non-Small Cell Lunch Cancer
| Record | Firm | Date |
|---|---|---|
| Safety and Efficacy of Buparlisib (BKM120) in Patients With Untreated Squamous Non-small Cell Lung Cancer (NCT01820325) | Novartis Pharmaceuticals | 2013-09-09 |
Track Non-Small Cell Lunch Cancer automatically
Every clearance here is in the API, with alerts when new ones post.